SCHEMBL7260711

SCHEMBL7260711

COc1cccc2c(=O)c(-c3ccccc3)c[nH]c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.62
ALDH1A1 P00352 3/20 0.62
HPGD P15428 3/20 0.62
DYRK1A Q13627 2/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
ATM Q13315 1/20 0.48
POLB P06746 2/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 1/20 0.48
BLM P54132 1/20 0.48
MCL1 Q07820 1/20 0.48
HTR2A P28223 1/20 0.47
PARP1 P09874 1/20 0.46
NFATC1 O95644 1/20 0.46
GSK3B P49841 1/20 0.46
NR3C1 P04150 1/20 0.45
PGR P06401 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7261286 0.89 ALDH1A1 (0.56) KDM4EALDH1A1HPGDDYRK1AMEN1
SCHEMBL2430387 0.83 ALDH1A1 (0.47) KDM4EALDH1A1HPGDDYRK1AMEN1
SCHEMBL7257608 0.81 RET (0.44) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL436409 0.78 ALDH1A1 (0.64) KDM4EALDH1A1HPGDDYRK1AMEN1
SCHEMBL7509122 0.77 KDM4E (1.00) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL7261298 0.77 POLB (0.53) KDM4EALDH1A1HPGDDYRK1AMEN1
SCHEMBL2429913 0.76 NR3C1 (0.48) KDM4EALDH1A1HPGDDYRK1AMEN1
SCHEMBL2432181 0.76 HPGD (0.43) KDM4EALDH1A1HPGDDYRK1AATM
Hydrochloric Acid SCHEMBL30353212 0.75 ALDH1A1 (0.97) KDM4EALDH1A1HPGDMEN1KMT2A
Ammonia Solution, Strong SCHEMBL28187483 0.75 ALDH1A1 (0.97) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645983-B1 Heterocyclic imines such as 3-(4-methoxyphenyl)-1,4-dihydro-4 -quinolinone, used as anticarcinogenic agents having cytolysis efficiency; side effect reduction LABORATOIRE L. LAFON (FR) 2003-11-11 US disclosed
EP-1202971-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES LABORATOIRE L. LAFON (FR) 2002-05-08 EP disclosed
WO-2002022074-A2 USE OF 2- AND 4- QUINOLONES FOR INHIBITING INTIMAL NEO-PROLIFERATION LABORATOIRE L. LAFON (FR) 2002-03-21 WO disclosed
WO-2001012607-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES FOR TREATING CANCERS LABORATOIRE L. LAFON (FR) 2001-02-22 WO disclosed